What tuberculosis can teach us about combating multidrug-resistant Gram negative bacilli
There are striking similarities between the dual pandemics of multidrug-resistant tuberculosis (MDR TB) and multidrug-resistant Gram negative bacilli (MDR GNB) despite fundamental differences in the pathogenesis and epidemiology of these pathogens. In this perspective, we highlight several strategie...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-05-01
|
Series: | Journal of Clinical Tuberculosis and Other Mycobacterial Diseases |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405579415300139 |
id |
doaj-acec3805e7394a1cb1a1b58c9628c5ed |
---|---|
record_format |
Article |
spelling |
doaj-acec3805e7394a1cb1a1b58c9628c5ed2020-11-24T21:00:04ZengElsevierJournal of Clinical Tuberculosis and Other Mycobacterial Diseases2405-57942016-05-0132834What tuberculosis can teach us about combating multidrug-resistant Gram negative bacilliRitu Banerjee0Jeffrey R. Starke1Division of Pediatric Infectious Diseases, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, United States; Corresponding author. Tel.: +1 507 255 8464; fax: +1 507 255 7767.Section of Infectious Diseases, Department of Pediatrics, Baylor College of Medicine, Houston, TX, United StatesThere are striking similarities between the dual pandemics of multidrug-resistant tuberculosis (MDR TB) and multidrug-resistant Gram negative bacilli (MDR GNB) despite fundamental differences in the pathogenesis and epidemiology of these pathogens. In this perspective, we highlight several strategies that have been used by the global TB community to address the MDR TB problem, including approaches to: encourage appropriate use of anti-TB medications, enhance appropriate utilization of molecular diagnostic testing, facilitate development of new antimicrobial agents, and strengthen surveillance systems and infection control practices. Understanding the successes and challenges of these strategies for MDR TB control will be instructive for efforts to curb emergence and spread of MDR GNB. Keywords: Multidrug-resistant, MDR, Tuberculosis, TB, Gram negative bacilli, GNBhttp://www.sciencedirect.com/science/article/pii/S2405579415300139 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ritu Banerjee Jeffrey R. Starke |
spellingShingle |
Ritu Banerjee Jeffrey R. Starke What tuberculosis can teach us about combating multidrug-resistant Gram negative bacilli Journal of Clinical Tuberculosis and Other Mycobacterial Diseases |
author_facet |
Ritu Banerjee Jeffrey R. Starke |
author_sort |
Ritu Banerjee |
title |
What tuberculosis can teach us about combating multidrug-resistant Gram negative bacilli |
title_short |
What tuberculosis can teach us about combating multidrug-resistant Gram negative bacilli |
title_full |
What tuberculosis can teach us about combating multidrug-resistant Gram negative bacilli |
title_fullStr |
What tuberculosis can teach us about combating multidrug-resistant Gram negative bacilli |
title_full_unstemmed |
What tuberculosis can teach us about combating multidrug-resistant Gram negative bacilli |
title_sort |
what tuberculosis can teach us about combating multidrug-resistant gram negative bacilli |
publisher |
Elsevier |
series |
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases |
issn |
2405-5794 |
publishDate |
2016-05-01 |
description |
There are striking similarities between the dual pandemics of multidrug-resistant tuberculosis (MDR TB) and multidrug-resistant Gram negative bacilli (MDR GNB) despite fundamental differences in the pathogenesis and epidemiology of these pathogens. In this perspective, we highlight several strategies that have been used by the global TB community to address the MDR TB problem, including approaches to: encourage appropriate use of anti-TB medications, enhance appropriate utilization of molecular diagnostic testing, facilitate development of new antimicrobial agents, and strengthen surveillance systems and infection control practices. Understanding the successes and challenges of these strategies for MDR TB control will be instructive for efforts to curb emergence and spread of MDR GNB. Keywords: Multidrug-resistant, MDR, Tuberculosis, TB, Gram negative bacilli, GNB |
url |
http://www.sciencedirect.com/science/article/pii/S2405579415300139 |
work_keys_str_mv |
AT ritubanerjee whattuberculosiscanteachusaboutcombatingmultidrugresistantgramnegativebacilli AT jeffreyrstarke whattuberculosiscanteachusaboutcombatingmultidrugresistantgramnegativebacilli |
_version_ |
1716780508590899200 |